As is known to all, appropriate exercise training plays a crucial role in cardiovascular function improvement for cardiovascular patients and healthy people [
3‐
5]. Actually, aerobic exercise has the ability to upgrade endothelial and vasomotor functions in CVD patients, thereby improving myocardial blood flow [
6]. What’s more, accumulating evidence has demonstrated that exercise training may contribute to changing MI-caused myocardial remodeling and ameliorating cardiac function [
7‐
10]. Notably, interval training (IT) has been confirmed to have more benefits in elevating peak oxygen uptake and oxygen among different aerobic exercise modes in patients with CVD [
11]. Currently, research has shown that IT is capable of augmenting cardiovascular health, but the specific regulatory mechanism remains unclear. Myocardial ischemia stands out as the main cause of MI, encouraging the overexpression of reactive oxygen species (ROS) in ischemic and surrounding myocardium [
12,
13]. The overexpression of ROS post-MI exacerbates the oxidative stress reaction and the production of inflammatory cytokines, which then damages the myocardial membrane and causes ischemic necrosis and apoptosis of cardiomyocytes [
14]. Myocardial ischemic injury will further trigger pathological cardiac remodeling, including compensatory hypertrophy of myocardial cells and myocardial fibrosis in the surrounding area of the infarction [
15,
16]. Remodeling of these myocardial cells deteriorates heart function, ultimately leading to cardiac dysfunction and heart failure [
17]. Due to the essential role of oxidative stress in left ventricular remodeling after MI, its inhibition has become the main therapeutic target for the mitigation of pathological remodeling and systolic dysfunction after MI [
18]. Transforming growth factor-β1 (TGF-β1), a crucial regulatory factor for cardiac fibrosis, possesses varying function, such as affecting cell growth, apoptosis, and differentiation, increasing the production of collagen and matrix protein, maintaining fibroblast viability, as well as suppressing the production of metalloproteinases that facilitates collagen degradation [
19,
20]. Significantly, high expression of TGF-β1 is observed in MI and blockage of the TGF-β1 pathway can alleviate myocardial fibrosis in MI mouse models [
21]. TGF-β family receptor is part of the serine/threonine kinase family, in which the type II receptor activates the kinase activity of type I receptor through phosphorylating its near membrane region [
22]. Guanxin V efficiently mitigates cell apoptosis, fibrosis, oxidative stress damage via down-regulating the TGF-β1 pathway, thereby mitigating MI [
23]. Moreover, exercise training is able to modulate the TGF-β1-Smad2/3-MMP2/9 pathway to diminish oxidative stress, myocardial fibrosis, and cell apoptosis, thus ameliorating myocardial function [
24]. The nod-like receptor protein 3 (NLRP3) inflammasomes, as a participant of inflammatory immune response, correlates closely with CVD [
25]. A previous study has attestedthat the NLRP3 inflammasomes are involved in the emergence and development of diseases including cardiomyopathy, ischemia-reperfusion injury (MIRI), arrhythmia [
26]. In MIRI, pubescenoside A restrains the activation of oxidative stress-initiated NLRP3 inflammasomes via the covalent modification of Keap1 at cysteine (Cys)77 and Cys434 [
27]. Consisting of caspase-1, NLRP3 and apoptosis-associated speck-like protein containing a CARD (ASC), the multi-protein inflammatory complex has a close relationship with MI [
28]. Additionally, alleviation of NLRP3-mediated inflammation and diminution of pro-inflammatory cytokine expression leads to reduced MI area and mitigated myocardial tissue remodeling, ultimately protecting cardiac function [
29]. Nevertheless, it remains unknown whether IT can inhibit the activation of NLRP3 inflammasomes by inactivating the TGF-β1 pathway, thereby improving cardiac function in MI rats. Therefore, the purpose of this study was to explore the mechanism, which provided partial theoretical basis for clarifying the pathogenesis of MI and new ideas for treating MI.